TTR and hydrops fetalis: ,4 The lack of significant differences in the risk of HF, AF, and VT between the SGLT2i and control groups may be due to the complex nature of ATTR-CM, where persistent high filling pressures and amyloid deposition in the myocardium predispose patients to HF decompensation and arrhythmias, necessitating additional therapeutic strategies.1